Development and Evaluation of Prednisolone Acetate-Loaded Nanostructured Lipid Carriers Integrated into pH-Triggered In Situ Gels for Ocular Drug Delivery
ASSAY and Drug Development Technologies · 2026
DOI: 10.1089/adt.2025.053 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2026. Verfasst von Sheetal Devi und 7 weiteren Autor:innen. Beteiligte Einrichtung: M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Mullana, Ambala, Haryana, India. Hauptthemen laut MEDLINE: Prednisolone, Drug Carriers, Lipids, Nanostructures. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
This study aimed to enhance the therapeutic efficacy of prednisolone by developing a nanostructured lipid carrier (NLC) system for topical ocular administration and addressing the limitations of current topical therapy. Drug-loaded NLCs (prednisolone acetate [PSA1]–PSA13) were formulated using high-pressure homogenization techniques, optimized with a central composite design, and evaluated for various pharmaceutical properties. An optimization study indicates that the lipid ratio and surfactant concentration influence particle size, entrapment efficiency (EE), and drug release. The optimized NLC formulation (PSA3) was integrated into a pH-triggered in situ gel system and assessed for drug permeation, ocular irritation, and stability. The optimized drug-loaded NLC formulations (PSA3) exhibited a nano size of 96.80 ± 0.51 nm, achieving an EE of 84.51 ± 1.31% and a drug release rate of 95.76 ± 1.23%. The drug permeation through the goat cornea was significantly higher in the in situ gel (PSAG4) compared with the control (marketed PSA eye drop). Additionally, the eye irritation data indicated good ocular tolerance, while stability studies confirmed that the developed formulation remained stable at room temperature. In conclusion, the developed NLC-based in situ gel appears to be a promising approach to enhancing the efficacy of prednisolone in topical therapy for the successful treatment of ocular inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Mullana, Ambala, Haryana, India.
- Global Research Institute of Pharmacy, Nachraun, Radaur, Pt. BD Sharma University of Health Science, Rohtak, Haryana, India.
- Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, Punjab, India.
- Center for Health Research, Northern Border University, Arar, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraidah, Saudi Arabia.
- Basic Medical Sciences Unit, Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia.
ORCID-Profile: Md Ali Mujtaba
Zitieren
APA
Devi, S., Saini, V., Mehan, N., Kumar, M., Mujtaba, M. A., Elhassan, G. O., Haider, N., & Warsi, M. H. (2026). Development and Evaluation of Prednisolone Acetate-Loaded Nanostructured Lipid Carriers Integrated into pH-Triggered In Situ Gels for Ocular Drug Delivery. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2025.053
Vancouver
Devi S, Saini V, Mehan N, Kumar M, Mujtaba MA, Elhassan GO, et al. Development and Evaluation of Prednisolone Acetate-Loaded Nanostructured Lipid Carriers Integrated into pH-Triggered In Situ Gels for Ocular Drug Delivery. ASSAY and Drug Development Technologies. 2026. doi:10.1089/adt.2025.053
BibTeX
@article{Devi2026,
author = {Devi, Sheetal and Saini, Vipin and Mehan, Navneet and Kumar, Manish and Mujtaba, Md Ali and Elhassan, Gamal Osman and Haider, Nafis and Warsi, Musarrat Husain},
title = {Development and Evaluation of Prednisolone Acetate-Loaded Nanostructured Lipid Carriers Integrated into pH-Triggered In Situ Gels for Ocular Drug Delivery},
journal = {ASSAY and Drug Development Technologies},
year = {2026},
doi = {10.1089/adt.2025.053}
}
EUVIMED